Quantitative studies of the kinetics of 5-aminolaevulinic acid-induced fluorescence in bladder transitional cell carcinoma
1998

Fluorescence Kinetics of ALA in Bladder Cancer

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): SN Datta, CS Loh, AJ MacRobert, SD Whatley, PN Matthews

Primary Institution: University Hospital of Wales

Hypothesis

The study aims to determine the fluorescence kinetics of ALA-induced PpIX in human transitional cell carcinoma compared to normal urothelium and detrusor muscle.

Conclusion

The study found that ALA-induced fluorescence in bladder tumors was significantly higher than in normal tissue, with no adverse events reported.

Supporting Evidence

  • Fluorescence in tumor tissue was twice that of normal urothelium in vitro and up to tenfold in vivo.
  • No patients experienced phototoxicity or other adverse events following intravesical instillation of ALA.
  • ALA generates a sensitizer called protoporphyrin IX (PpIX) in situ, which is more tumor-specific.

Takeaway

This study looked at how a special drug helps doctors see bladder tumors better without hurting the patients.

Methodology

The study involved in vitro and in vivo investigations of fluorescence kinetics using biopsies from patients with bladder cancer.

Limitations

The study did not include long-term follow-up data on disease progression or survival.

Participant Demographics

Patients included those with a history of superficial transitional cell carcinoma of the bladder.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication